Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells

Journal of Drug Targeting

Volumn 18, Issue 6, 2010, Pages 447-456

  Kuo, Yung Chih ^a   Chen, Hung Hao ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Bloodbrain barrier; Cationic solid lipid nanoparticle; Clathrin; Electromagnetic field; Endocytosis; Human brain microvascular endothelial cell; P glycoprotein

Indexed keywords

CATIONIC SOLID LIPID NANOPARTICLE; CLATHRIN; GLYCOPROTEIN P; NANOPARTICLE; SAQUINAVIR; UNCLASSIFIED DRUG; AMINE; CATION; DIMETHYLDIOCTADECYLAMMONIUM; LIPID; MULTIDRUG RESISTANCE PROTEIN; OCTADECYLAMINE; QUATERNARY AMMONIUM DERIVATIVE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROCIRCULATION; CELL MEMBRANE; CONTROLLED STUDY; DRUG PENETRATION; ELECTROMAGNETIC FIELD; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; NANOENCAPSULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; BRAIN; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; DRUG DELIVERY SYSTEM; METABOLISM; MICROVASCULATURE; PROCEDURES; VASCULARIZATION;

AMINES; BLOOD-BRAIN BARRIER; BRAIN; CATIONS; CELL CULTURE TECHNIQUES; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CLATHRIN; DRUG DELIVERY SYSTEMS; ELECTROMAGNETIC FIELDS; ENDOCYTOSIS; ENDOTHELIAL CELLS; HUMANS; LIPIDS; MICROVESSELS; NANOPARTICLES; P-GLYCOPROTEIN; QUATERNARY AMMONIUM COMPOUNDS; SAQUINAVIR;

EID: 77953280522     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903494245     Document Type: Article

References (44)

1. Abbott NJ. (2005). Dynamics of CNS barriers: evolution, differentiation,and modulation.Cell Mol Neurobiol, 25:5-23.
2. Abbott NJ. (2004). Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int, 45:545-552.
3. Abbott NJ, Romero IA. (1994). Transporting therapeutics across the blood-brain barrier.Mol Neurobiol, 2:106-113.
4. Callahan MK, Williams KA, Kivisäkk P, Pearce D, Stins MF, Ransohoff RM. (2004). CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer. J Neuroimmunol, 153:150-157.
5. Catelas I, Petit A, Marchand R, Zukor DJ, Yahia L, Huk OL. (1999). Cytotoxicity and macrophage cytokine release induced by ceramic and polyethylene particles in vitro. J Bone Joint Surg Br, 81:516-521. (Pubitemid 29245912)
6. Chen Y, Dalwadi G, Benson HA. (2004). Drug delivery across the blood-brain barrier. Curr Drug Deliv, 1:361-376.
7. Chiabrera A, Bianco B, Moggia E, Kaufman JJ. (2000). Zeeman-Stark modeling of the RF EMF interaction with ligand binding. Bioelectromagnetics, 21:312-324.
8. Cosquer B, de Vasconcelos AP, Fröhlich J, Cassel J. (2005). Blood-brain barrier and electromagnetic field: effects of scopolamine methylbromide on working memory after whole-body exposure to 2.45 GHz microwaves in rats. Behav. Brain Res, 161, 229-237
9. Cserr HF, Bundgaard M. (1984). Blood-brain interfaces in vertebrates: a comparative approach. Am J Physiol, 246:R277-R288.
10. Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R. (1997). A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol, 138:877-889.
11. El-Sayed M, Ginski M, Rhodes C, Ghandehari H. (2002). Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release, 81:355-365.
12. Gaillard PJ, de Boer AG. (2000). Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. Eur J Pharm Sci, 12:95-102.
13. Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R, Frei K. (2001). Molecular and cellular permeability control at the blood- brain barrier.Brain Res Rev, 36:258-264.
14. Hawkin BT, Davis TP. (2005). The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev, 57:173-185.
15. Hayashi S, Murakami Y. (1995). Rapid and regulated degradation of ornithine decarboxylase. Biochem J,306 (Pt 1):1-10.
16. Koziara JM, Lockman PR, Allen DD, Mumper RJ. (2004). Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release, 99:259-269.
17. Kreuter J. (2005). Application of nanoparticles for the delivery of drugs to the brain. Int Congr Ser, 1277:85-94.
18. Kreuter J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev, 47:65-81.
19. Kuo YC, Kuo CY. (2008). Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers. Int J Pharm, 351:271-281.
20. Kuo YC, Lin SC. (2008). Effect of glutamate on the electrical properties of cationic solid lipid nanoparticles containing stearylamine and dioctadecyldimethyl ammonium bromide. J Phys Chem B, 112:4454-4460.
21. Kuo YC, Chen IC. (2007). Evaluation of surface charge density and surface potential by electrophoretic mobility for solid lipid nanoparticles and human brain-microvascular endothelial cells. J Phys Chem B, 111:11228-11236.
22. Kuo YC, Su FL. (2007). Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int J Pharm, 340:143-152.
23. Kuo YC, Chen HH. (2006). Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier. Int J Pharm, 327:160-169.
24. Kuo YC, Lin TW. (2006). Electrophoretic mobility, zeta potential, and fixed charge density of bovine knee chondrocytes, methyl methacrylate- sulfopropyl methacrylate, polybutylcyanoacrylate, and solid lipid nanoparticles. J Phys Chem B, 110:2202-2208.
25. Kuo YC. (2005). Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles. Int J Pharm, 290:161-172.
26. Kusch-Poddar M, Drewe J, Fux I, Gutmann H. (2005). Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier. Brain Res, 1064:21-31.
27. Lee VH. (2000). Membrane transporters. Eur J Pharm Sci, 11 Suppl 2:S41-S50.
28. Madara JL. (1998). Regulation of the movement of solutes across tight junctions. Annu Rev Physiol, 60:143-159.
29. Mahrour N, Pologea-Moraru R, Moisescu MG, Orlowski S, Levêque P, Mir LM. (2005).In vitro increase of the fluid-phase endocytosis induced by pulsed radiofrequency electromagnetic fields: importance of the electric field component. Biochim Biophys Acta, 1668:126-137.
30. Markkanen A, Penttinen P, Naarala J, Pelkonen J, Sihvonen AP, Juutilainen J. (2004). Apoptosis induced by ultraviolet radiation is enhanced by amplitude modulated radiofrequency radiation in mutant yeast cells. Bioelectromagnetics, 25:127-133.
31. McAllister MS, Krizanac-Bengez L, Macchia F, Naftalin RJ, Pedley KC, Mayberg MR, Marroni M, Leaman S, Stanness KA, Janigro D. (2001). Mechanisms of glucose transport at the blood-brain barrier: an in vitro study. Brain Res, 904:20-30.
32. Penafiel LM, Litovitz T, Krause D, Desta A, Mullins JM. (1997). Role of modulation on the effect of microwaves on ornithine decarboxylase activity in L929 cells. Bioelectromagnetics, 18:132-141.
33. Poduslo JF, Curran GL. (1996). Polyamine modification increases the permeability of proteins at the blood-nerve and blood-brain barriers. J Neurochem, 66:1599-1609.
34. Polli JW, Jarrett JL, Studenberg SD, Humphreys JE, Dennis SW, Brouwer KR, Woolley JL. (1999). Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor. Pharm Res, 16: 1206-1212.
35. Rubin LL, Staddon JM. (1999). The cell biology of the blood-brain barrier. Annu Rev Neurosci, 22:11-28.
36. Schinkel AH. (1999). P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev, 36:179-194.
37. Schöler N, Hahn H, Müller RH, Liesenfeld O. (2002). Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages. Int J Pharm, 231:167-176.
38. Trout JJ, Koenig H, Goldstone AD, Lu CY. (1986). Blood-brain barrier breakdown by cold injury. Polyamine signals mediate acute stimulation of endocytosis, vesicular transport, and microvillus formation in rat cerebral capillaries. Lab Invest, 55:622-631.
39. Tsuji A, Tamai I. (1997). Blood-brain barrier function of P-glycoprotein. Adv Drug Deliv Rev, 25:287-298.
40. Varani K, Gessi S, Merighi S, Iannotta V, Cattabriga E, Pancaldi C, Cadossi R, Borea PA. (2003). Alteration of A(3) adenosine receptors in human neutrophils and low frequency electromagnetic fields. Biochem Pharmacol, 66:1897-1906.
41. Weisgraber KH, Innerarity TL, Harder KJ. (1983). The receptor-binding domain of human apolipoprotein E: monoclonal antibody inhibition of binding. J Biol Chem, 258:12348-12354.
42. Williams WM, Hoss W, Formaniak M, Michaelson SM. (1984). Effect of 2450-MHz microwave energy on the blood-brain barrier to hydrophilic molecules: effect on the permeability to HRP. Brain Res, 319:171-181.
43. Wolburg H, Lippoldt A. (2002). Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol, 38:323-337.
44. Yu A. 2005. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol, 288:1231-1241.